Source: Zacks Investment Research
Colgate-Palmolive is strengthening its market position through innovation, premiumization of oral-care products, and expansion in emerging markets. The company is introducing differentiated products targeting whitening, sensitivity, and gum health, while leveraging its strong global brands. However, sustaining momentum depends on balancing pricing with volume, successful product launches, and cost management. Colgate trades at a premium valuation (21.5X forward P/E vs. industry 18.4X) with modest EPS growth projected at 4.9% for 2026 and 5.2% for 2027.
Source: Zacks Investment Research
McCormick & Company is expected to report Q3 2026 revenues rising 14.7% to ~$2 billion, but earnings may fall 11.8% to 75 cents per share. Growth drivers include the Flavor Solutions segment, pricing actions, and CCI productivity savings, while headwinds include consumer price sensitivity, competitive pressures, and inflationary expenses. The company carries a Zacks Rank #4 (Sell) with a negative Earnings ESP of -1.97%, suggesting limited likelihood of an earnings beat.
Source: The Motley Fool
Colgate-Palmolive was removed from the S&P 100 index due to its $69 billion market cap being eclipsed by faster-growing AI-driven stocks, but the company remains a solid long-term investment. With 63 consecutive years of dividend increases, a 347% total return over 20 years, and expected 17% EPS CAGR through 2028, the stock offers stability and growth potential despite being a slower-growth consumer staples company.
Source: Zacks Investment Research
Procter & Gamble faces a $1.4 billion after-tax earnings headwind in fiscal 2027 as it attempts to balance pricing strategies with volume growth in a challenging consumer environment. While pricing contributed to 1% organic sales growth in fiscal 2026, volume remained flat in Q4. PG plans to shift toward more balanced growth through innovation, promotions, and disciplined pricing rather than relying solely on price increases, which risk consumer trade-downs and reduced purchase frequency.
Source: Zacks Investment Research
Colgate-Palmolive (CL) is addressing weak North America performance in Q2 2026 caused by soft category trends, competitive pressure, and retailer destocking. The company plans to boost premium toothpaste products, expand Fabuloso, increase advertising spending, and implement targeted pricing to drive market-share recovery in the second half of 2026. Management expects sequential improvement but cautioned recovery will be uneven and dependent on consumer demand health.
Source: Zacks Investment Research
Procter & Gamble's Fabric & Home Care segment shows early improvement with Tide original liquid shifting to high-single-digit growth following a major product upgrade, while Tide evo and fabric enhancers offer future growth potential. However, European competition remains intense and Home Care faces headwinds. Church & Dwight and Colgate-Palmolive are also sustaining momentum through innovation and brand strength, though competitive pressures and uneven consumer demand persist across the household care sector.
Source: The Motley Fool
Nike has been removed from the S&P 100 effective September 21 as part of quarterly rebalancing, marking a significant decline for the company. With stock prices at 12-year lows, declining revenue and earnings, and operating margins plummeting, Nike is now the lowest-ranked component in the Dow Jones Industrial Average, putting its membership in jeopardy. The article suggests investors should wait for concrete signs of a sustained turnaround before buying the stock.
Source: Zacks Investment Research
A comparison of two Consumer Products - Staples stocks reveals that National Vision (EYE) offers better value than Colgate-Palmolive (CL). EYE has a Zacks Rank of #2 (Buy) with improving earnings outlook, a lower forward P/E of 17.51, and a Value grade of B. CL has a Zacks Rank of #3 (Hold), higher forward P/E of 22.74, and a Value grade of D, making EYE the superior value option.
Source: GlobeNewswire Inc.
The global skin care products market is projected to grow from USD 166 billion in 2025 to USD 262 billion by 2034, with a CAGR of approximately 5%. Growth is driven by rising consumer awareness of skin health, increasing disposable incomes, demand for premium and personalized products, and the influence of social media trends. Asia-Pacific leads with 38% market share, while North America is the fastest-growing region. Key players include L'Oréal, Unilever, Procter & Gamble, and Estée Lauder.
Source: Zacks Investment Research
Procter & Gamble's Fabric & Home Care segment displays mixed performance with Fabric Care showing low-single digit growth while Home Care declined in Q4 fiscal 2026. The company faces competitive pressure in Europe but is seeing improvement in U.S. Fabric Care momentum and China share growth. Innovation initiatives like Tide upgrades and Mr. Clean expansions are driving growth, though the segment remains a concern overall.
Source: Zacks Investment Research
Procter & Gamble enters fiscal 2027 with strong brands and cash generation but faces headwinds from modest growth expectations of 1-3% organic sales and flat to 3% core EPS growth. Trading at a 20.3X forward earnings premium relative to peers, PG's valuation leaves little room for error despite productivity improvements and selective innovation success. The company maintains robust cash returns through dividends and buybacks but carries near-term execution risks.
Source: Zacks Investment Research
Procter & Gamble expects fiscal 2027 to face a $1.4 billion after-tax earnings headwind (56 cents per share), driven by $1 billion in higher input costs, increased financing expenses, lower non-operating income, and unfavorable currency. Despite 1-3% expected organic sales growth, the company projects flat to 3% core EPS growth, relying on productivity improvements and brand investments to offset pressures.
Source: GlobeNewswire Inc.
The global pet treats market is projected to grow at a CAGR of 8.9% from USD 38.40 billion in 2026 to USD 58.71 billion by 2031, driven by increasing pet ownership, pet humanization, and rising demand for premium, functional treats with natural ingredients. Jerky and meat-based treats dominate the market, while freeze-dried products and e-commerce channels show the fastest growth. Asia Pacific is expected to be the fastest-growing region.
Source: The Motley Fool
The article recommends three consumer staples companies for dividend-focused investors: Unilever (3.5% yield) as a global anchor with everyday brands, Colgate-Palmolive (2.4% yield) as a reliable hygiene-focused play, and Mondelez (3.2% yield) as a growth-leaning snack company with emerging market exposure. Together, they provide a diversified income portfolio backed by strong brand loyalty and consistent dividend growth.
